ArticleFrontiers in oncology2018

A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity.

Meinolf Thiemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.